Log in
Enquire now
Treos Bio

Treos Bio

Treos Bio is a next-generation off-the-shelf peptide cancer immunotherapies developer founded in 2013 by John Hautman.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
Business Model
Commerce
CEO
Christopher Gallen
Christopher Gallen
0
CFO
‌
Gabor Illes
Legal Name
Treos Bio, Inc.
Country
United Kingdom
United Kingdom
0
Crunchbase URL
crunchbase.com/organiz...reos-bio
Email Address
info@treosbio.com
0
mlevitan@soleburytrout.com
0
zlockshin@soleburytrout.com
0
Founded Date
2013
Founder
‌
John Hautman
Full Address
The Harley Building 79 New Cavendish Street London W1W 6XB United Kingdom
0
Headquarters
London
London
Industry
Engineering
Engineering
Healthcare
Healthcare
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Genetics
Genetics
Vaccine
Vaccine
Biomedical engineering
Biomedical engineering
Clinical trial
Clinical trial
Investors
BXR Partners LLP
BXR Partners LLP
Latest Funding Round Date
August 27, 2025
Latest Funding Round Amount (USD)
2,100,000
Latest Funding Type
‌
Venture round
Legal classification
Corporation
Corporation
LinkedIn URL
@company/treos-bio-limited/people
Location
United Kingdom
United Kingdom
London
London
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
+16463782960
0
+442031417370
0
Pitchbook URL
pitchbook.com/profiles...170517-97
Total Funding Amount (USD)
10,100,000
Official Website
treosbio.com

Find more companies like Treos Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.